In Vivo 18 F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy (2022)
Attributed to:
A new noradrenergic strategy to treat Impulsivity in Progressive Supranuclear Palsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.121.262985
PubMed Identifier: 34795013
Publication URI: http://europepmc.org/abstract/MED/34795013
Type: Journal Article/Review
Parent Publication: Journal of Nuclear Medicine
Issue: 7
ISSN: 0161-5505